Agribusiness · Business Strategy
Biologicals: growth demands evidence, brand and trust

How to prepare positioning and commercial communications for competition in Latin American markets.
A company can develop a promising biological solution and still struggle to start commercial conversations. Its product has technical support, yet its proposition remains unclear to those who must assess it, recommend it or add it to a portfolio. That gap between capability and understanding deserves strategic attention.
For manufacturers, distributors and international companies seeking growth in Latin America, the challenge is to connect evidence, positioning and commercial execution. Communications should help customers understand what they can expect, under which conditions and with what support.
New brands raise new competitive questions
On November 5, 2026, Bayer published its announcement of Biológicos Bayer and 17 planned launches in Latin America by 2030, eight in Brazil. These are announced plans, not confirmed commercial availability. In October, BioFirst announced its purchase of the remaining stake in Biotrop, completing full ownership.
At AgenciaAgro, we interpret these developments as a reason to review how each business presents itself to the market. A brand needs to explain its role, organize its portfolio and offer clear reasons to be considered. Corporate announcements provide competitive context; they do not, by themselves, establish agronomic efficacy or predict who will gain market share.
Turn evidence into arguments buyers can assess
In agricultural biologicals marketing, describing a solution as innovative leaves important questions unanswered. Which crop and need does it address? What was evaluated? Under which conditions? What information does an adviser need to assess its place within a crop management program?
We recommend organizing available evidence with the technical team: trial objective, location, season, comparator, results and limitations. Commercial materials can make the findings easier to read while providing access to the underlying documentation. An average presented without context gives a decision maker fewer useful grounds for evaluation.
Each solution also needs a clearly defined role within the portfolio. Treating biologicals as a uniform category can obscure meaningful differences. Messages should reflect the product, its documentation and authorized uses in each market. Marketing and technical teams need a shared understanding of which claims they can support and how to explain them.
Build a proposition for each decision maker
A grower may prioritize integration into an existing crop management program. An adviser needs to understand the rationale and assess supporting evidence. A distributor must evaluate the commercial opportunity, training and support available. A single presentation is unlikely to answer all these questions equally well.
A B2B communications strategy should start with those decisions. Advisers need an accessible technical summary and a route to the trial documentation. Channel partners need portfolio arguments, training materials and responses to objections. Prospective customers need a page that clearly explains the proposition and makes a relevant inquiry straightforward.
Adaptation requires consistency. The website, presentations and sales team should share a central promise and the same boundaries around their claims. Conflicting messages can create uncertainty precisely when the company is trying to build confidence.
Prepare expansion before increasing communications activity
International expansion requires a clear choice of where and with whom to grow. We recommend starting with a specific combination of market, crop, need and channel. Then review language, technical references, product availability and the ability to provide local support.
This work helps prioritize content and commercial tools. A business seeking distributors needs to explain how it will support commercialization. A company preparing a launch needs a sequence connecting introduction, technical explanation, inquiries and follow-up. Both need clear ownership of the next conversation.
To assess progress, we suggest monitoring inquiries from target accounts, qualified meetings, requests for technical information and opportunities that advance through the sales process. Website visits and interactions can help explain reach, but they need to be connected to those commercial objectives.
A growth decision for business leaders
Before investing in a new campaign, review whether the proposition is understandable, whether evidence is accessible and whether the team can support the conversation the campaign aims to generate.
Is your business preparing a biologicals launch, developing its channel or entering new markets? AgenciaAgro connects brand strategy, technical communications and agribusiness marketing to support B2B lead generation and international expansion. Let us discuss your next stage of growth.
Sources
Bayer, announcement concerning Biológicos Bayer, November 5, 2026
BioFirst Group, announcement concerning Biotrop ownership, October 5, 2026
Strategic analysis: AgenciaAgro. Information checked on November 19, 2026.




